Aspirin for primary prevention of cardiovascular disease?

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Background:

• Cardiovascular disease (CVD) is a major global cause of mortality.
• Aspirin is widely used for secondary prevention of vascular events.
• The role of aspirin in primary CVD prevention remains uncertain, particularly regarding risk-benefit balance.

Purpose of the Study:

• To evaluate the role of low-dose aspirin in the primary prevention of cardiovascular disease.
• To weigh the potential benefits of aspirin against its risks in individuals without a history of CVD.

Main Methods:

• Review of existing literature and clinical guidelines on low-dose aspirin for primary CVD prevention.
• Analysis of data concerning aspirin's efficacy and safety profile in non-high-risk populations.

Main Results:

• Evidence suggests that the benefits of primary aspirin use for CVD prevention may not outweigh the associated risks.
• Long-term low-dose aspirin therapy is associated with a significantly increased risk of gastrointestinal hemorrhage.

Conclusions:

• Low-dose aspirin is not recommended for primary prevention of cardiovascular events in individuals without a history of CVD.
• The decision to use aspirin for primary prevention should carefully consider the increased risk of bleeding complications.